Entera Bio Ltd Share Price Today: Live Updates & Key Insights

Entera Bio Ltd share price today is $1.12, up -6.72%. The stock opened at $1.18 against the previous close of $1.19, with an intraday high of $1.18 and low of $1.08.

Entera Bio Ltd Share Price Chart

Entera Bio Ltd

us-stock
To Invest in {{usstockname}}
us-stock

Entera Bio Ltd Share Price Performance

$1.12 -0.0672(-6.72%) ENTX at 23 Mar 2026 12:53 PM Biotechnology
Lowest Today 1.08
Highest Today 1.18
Today’s Open 1.18
Prev. Close 1.19
52 Week High 3.22
52 Week Low 1.00
Day’s Range: Low 1.08 High 1.18
52-Week Range: Low 1.00 High 3.22
1 day return -
1 Week return -17.4
1 month return -30.31
3 month return -40.69
6 month return -39.07
1 year return -41.62
3 year return +6.19
5 year return -76.35
10 year return -

Entera Bio Ltd Institutional Holdings

Knoll Capital Management LP 12.83

Point72 Asset Management, L.P. 2.57

Marshall Wace Asset Management Ltd 1.37

Schonfeld Strategic Advisors LLC 1.30

Parkman Healthcare Partners LLC 0.60

Northern Trust Corp 0.32

Seven Fleet Capital Management LP 0.30

Renaissance Technologies Corp 0.24

Jane Street Group LLC 0.16

Susquehanna International Group, LLP 0.14

Signature Estate & Investment Advisors 0.10

HighTower Advisors, LLC 0.09

Citadel Advisors Llc 0.09

Fidelity Nasdaq Composite Index 0.05

Geode Capital Management, LLC 0.05

Bank of America Corp 0.05

GSA Capital Partners LLP 0.03

XTX Topco Ltd 0.02

UBS Group AG 0.02

PNC Financial Services Group Inc 0.02

Cubist Systematic Strategies, LLC 0.01

Entera Bio Ltd Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Entera Bio Ltd Fundamentals

Market Cap 50.90 M

PB Ratio 3.3413

PE Ratio 0.0

Enterprise Value 42.54 M

Total Assets 9.39 M

Volume 152190

Entera Bio Ltd Company Financials

Annual Revenue FY23:14000 0.0M, FY22:134000 0.1M, FY21:571000 0.6M, FY20:365000 0.4M, FY19:236000 0.2M

Annual Profit FY23:6000 0.0M, FY22:33000 0.0M, FY21:198000 0.2M, FY20:156000 0.2M, FY19:26000 0.0M

Annual Net worth FY23:-9929000 -9.9M, FY22:-13071000 -13.1M, FY21:-12187000 -12.2M, FY20:-9983000 -10.0M, FY19:-10879000 -10.9M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:42000 0.0M, Q3/2024:42000 0.0M, Q2/2024:57000 0.1M

Quarterly Profit Q3/2025:-8000 -0.0M, Q2/2025:-7000 -0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:9000 0.0M

Quarterly Net worth Q3/2025:-3200000 -3.2M, Q2/2025:-2656000 -2.7M, Q1/2025:-2567000 -2.6M, Q3/2024:-3021000 -3.0M, Q2/2024:-2145000 -2.1M

About Entera Bio Ltd & investment objective

Company Information Entera Bio Ltd., a clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs. The company leverages its N-Tab platform that is designed to simultaneously stabilize the peptide in the gastrointestinal tract and promote its absorption into the bloodstream. It also develops EB613, an oral PTH (1-34), that has completed Phase 2 clinical trial for the treatment of post-menopausal women with low bone mineral density and high-risk osteoporosis; and has completed Phase 1 clinical trial to treat stress fractures. In addition, the company is developing EB612, a tablet peptide replacement therapy for hypoparathyroidism. Further, it develops oral oxyntomodulin (OXM), a dual targeted GLP1/glucagon peptide, in tablet form for the treatment of obesity and metabolic disorders; and GLP-2 peptide tablet as an injection-free alternative for patients suffering from rare malabsorption conditions, such as short bowel syndrome. The company has research collaboration agreement with OPKO Biologics, Inc. Entera Bio Ltd. was incorporated in 2009 and is headquartered in Jerusalem, Israel.

Organisation Biotechnology

Employees 20

Industry Biotechnology

CEO Ms. Miranda J. Toledano M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Entera Bio Ltd FAQs

What is the share price of Entera Bio Ltd today?

The current share price of Entera Bio Ltd is $1.12.

Can I buy Entera Bio Ltd shares in India?

Yes, Indian investors can buy Entera Bio Ltd shares by opening an international trading and demat account with Motilal Oswal.

How to buy Entera Bio Ltd shares in India?

You can easily invest in Entera Bio Ltd shares from India by:

Can I buy fractional shares of Entera Bio Ltd?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Entera Bio Ltd?

Entera Bio Ltd has a market cap of $50.90 M.

In which sector does Entera Bio Ltd belong?

Entera Bio Ltd operates in the Biotechnology sector.

What documents are required to invest in Entera Bio Ltd stocks?

To invest, you typically need:

What is the PE and PB ratio of Entera Bio Ltd?

The PE ratio of Entera Bio Ltd is N/A and the PB ratio is 3.34.